biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jan 12, 2018 7:43pm

212 Views

Post# 27346872

RE:RE:RE:The share price tells us something

He is right . Nobody is interesyed in bti. Year after year and board after board.

Oh no! That sounds pretty serious! Why are you still in the stock?

They're working on "IND enabling studies" in H1 2018 for Herceptin/trastazumab. Plus 2 other pre-clinical research programs. Plus NHP studies. Plus maybe licensing opportunities. Plus whatever else I forgot. Plus whatever else we don't know about....

Wait for it or don't wait for it. Pick one.

Bullboard Posts

Canadian artificial intelligence ETFs